According to our data, most of the biomarkers evaluated to study IBD are specific inflammation markers (IFN-γ, TNF-α, IL-6, IL-10, and MPO) that intend to represent and prove the reliability of the induction method used, as well as to verify the occurrence of inflammation in the intestine. This evidence concerns the gene TNF and inflammatory bowel disease.